[1]
G. Tan, W. Feng, D. Yang, and J. Pu, “Targeted Therapy and Immunotherapy are Novel Treatment Plans of Hepatocellular Carcinoma that is not Amenable to Surgical Resection: Emerging Trends in Combined Treatment Strategies”, IJBLS, vol. 16, no. 2, pp. 83–91, Aug. 2026, doi: 10.54097/kk0j7n02.